研究论文开放获取
Safety of Damoctocog Alfa Pegol in Patients With Severe Haemophilia A Aged 7 to <12 Years of Age: Pooled Data From PROTECT VIII Kids and Alfa‐PROTECT
Margareth C Ozelo, Anthony K. C. Chan, Matteo Luciani, Monika Maas Enriquez, Claudia Tueckmantel, Maria Elisa Mancuso
Universidade Estadual de Campinas (UNICAMP) McMaster Children's Hospital McMaster University Bambino Gesù Children's Hospital
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
摘要 · 节选
暂未获取摘要。可打开原文或 PDF，后续可基于全文生成更完整的速读。
逐年被引趋势
暂无年度引用数据
关键指标
0
被引次数 · OpenAlex
0.00
领域内被引倍数
同类平均 = 1
同类平均 = 1
前 28%
引用位次
同领域 · 同年份 · 同类型
同领域 · 同年份 · 同类型
3
参考文献
Google Scholar 与 OpenAlex 的被引统计范围不同，数值存在差异属正常。
AI 辅助阅读
依据：文献信息
论文问答
当前基于文献信息回答
可就本文提问；依据不足时会说明。
学术脉络
学科主题
生物医学Hemophilia Treatment and Research
Platelet Disorders and Treatments · Coagulation, Bradykinin, Polyphosphates, and Angioedema
参考文献 3
PROTECT VIII Kids: BAY 94‐9027 (PEGylated Recombinant Factor VIII) safety and efficacy in previously treated children with severe haemophilia A
被引 30Elena Santagostino, Gili Kenet, Kathelijn Fischer · Haemophilia · 2020
PROTECT VIII kids extension study: Long‐term safety and efficacy of BAY 94‐9027 (damoctocog alfa pegol) in children with severe haemophilia A
被引 14Maria Elisa Mancuso, Tina T. Biss, Kathelijn Fischer · Haemophilia · 2021
Safety and Efficacy of Damoctocog Alfa Pegol in Previously Treated Children Aged 7 to < 12 Years With Severe Haemophilia A in the Phase 3, Open Label Alfa‐ PROTECT Main Study
被引 3Margareth C Ozelo, Matteo Luciani, Heidi Glosli · European Journal Of Haematology · 2026
此处列出前 3 条
引用本文 -
暂无引用本文的记录